{
    "id": "35d2e40e-8f0d-ef2d-e063-6294a90aadc0",
    "warningsAndPrecautions": "product : 17856-3728 ndc : 17856-3728-01 propranolol hcl 20mg/5ml - 5 ml cup 72 ct ud distributed : atlantic biologicals corp. miami , fl 33179",
    "adverseReactions": "propranolol hydrochloride contraindicated : 1 ) cardiogenic shock ; 2 ) sinus bradycardia greater first degree block ; 3 ) bronchial asthma ; 4 ) patients known hypersensitivity propranolol hydrochloride .",
    "ingredients": [
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M"
        },
        {
            "name": "CITRIC ACID MONOHYDRATE",
            "code": "2968PHW8QP"
        },
        {
            "name": "EDETATE DISODIUM",
            "code": "7FLD91C86K"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH"
        },
        {
            "name": "SACCHARIN SODIUM",
            "code": "SB8ZUX40TY"
        },
        {
            "name": "SORBITOL",
            "code": "506T60A25R"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "PROPRANOLOL HYDROCHLORIDE",
            "code": "F8A3652H1V"
        }
    ],
    "organization": "ATLANTIC BIOLOGICALS CORP.",
    "name": "Propranolol Hydrochloride",
    "effectiveTime": "20250523",
    "warningsAndPrecautions_original": "Product: 17856-3728\n                  NDC: 17856-3728-01 PROPRANOLOL HCL 20MG/5ML - 5 ML CUP 72 ct UD\n                  \n                  \n                     DISTRIBUTED BY: \n                  \n                  \n                     ATLANTIC BIOLOGICALS CORP. \n                  \n                  \n                     MIAMI, FL 33179",
    "adverseReactions_original": "Propranolol hydrochloride is contraindicated in: 1) cardiogenic shock; 2) sinus bradycardia and greater than first degree block; 3) bronchial asthma; and 4) in patients with known hypersensitivity to propranolol hydrochloride."
}